Amedeo's Top 20

Amedeo Smart

Independent Medical Education


18 June 2018

Multidisciplinary Journal Club

  1. Prosperini L, Lucchini M, Haggiag S, Bellantonio P, et al.
    Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.
    Neurology 2018.

  1. Caraceni P, Riggio O, Angeli P, Alessandria C, et al.
    Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
    Lancet 2018.

  2. Francis PA, Pagani O, Fleming GF, Walley BA, et al.
    Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
    N Engl J Med 2018.

  3. Sparano JA, Gray RJ, Makower DF, Pritchard KI, et al.
    Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
    N Engl J Med 2018.

  4. Heemskerk AD, Nguyen MTH, Dang HTM, Vinh Nguyen CV, et al.
    Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.
    Clin Infect Dis 2017.

  1. Hoffman RM, Brummel SS, Britto P, Pilotto JH, et al.
    Adverse Pregnancy Outcomes among Women who Conceive on Antiretroviral Therapy.
    Clin Infect Dis 2018.

  2. McDanel JS, Roghmann MC, Perencevich EN, Ohl ME, et al.
    Comparative Effectiveness of Cefazolin versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
    Clin Infect Dis 2017.

  3. Combes A, Hajage D, Capellier G, Demoule A, et al.
    Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.
    N Engl J Med 2018;378:1965-1975.

  4. Dheda K, Lenders L, Magombedze G, Srivastava S, et al.
    Drug Penetration Gradients Associated with Acquired Drug Resistance in Tuberculosis Patients.
    Am J Respir Crit Care Med 2018.

  5. Langhorne P, O'Donnell MJ, Chin SL, Zhang H, et al.
    Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.
    Lancet 2018;391:2019-2027.

  1. Huguet F, Chevret S, Leguay T, Thomas X, et al.
    Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial.
    J Clin Oncol 2018.

  2. Lambertini M, Campbell C, Bines J, Korde LA, et al.
    Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
    J Natl Cancer Inst 2018.

  3. Burns RB, Rosen H, Berry S, Smetana GW, et al.
    How Would You Manage This Patient With Osteoporosis?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med 2018;168:801-808.

  4. Podlipnik S, Moreno-Ramirez D, Carrera C, Barreiro A, et al.
    Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with AJCC stage IIB, IIC and III malignant melanoma.
    Br J Dermatol 2018.

  5. Tung NM, Garber JE.
    BRCA1/2 testing: therapeutic implications for breast cancer management.
    Br J Cancer 2018.

  1. Slamon DJ, Neven P, Chia S, Fasching PA, et al.
    Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.
    J Clin Oncol 2018.

  2. Mussi-Pinhata MM, Yamamoto AY, Aragon DC, Duarte G, et al.
    Seroconversion for Cytomegalovirus infection during pregnancy and fetal infection in a highly seropositive population: "The BraCHS Study".
    J Infect Dis 2018.

  3. Ishida JH, McCulloch CE, Steinman MA, Grimes BA, et al.
    Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients.
    J Am Soc Nephrol 2018.

  4. Kanis JA, Cooper C, Rizzoli R, Reginster JY, et al.
    Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Osteoporos Int 2018.

  5. Ali A, Ng HL, Blankson JN, Burton DR, et al.
    Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1.
    J Infect Dis 2018.


more..


Privacy Policy